Kawakami, Kazuki
Ohya, Masaki http://orcid.org/0000-0002-7789-8184
Yashiro, Mitsuru
Sonou, Tomohiro
Yamamoto, Shuto
Nakashima, Yuri
Yano, Takuro
Tanaka, Yusuke
Ishida, Koichi
Kobashi, Seiichi
Shigematsu, Takashi
Araki, Shin-ichi
Funding for this research was provided by:
Fuji Yakuhin Co.Ltd (Fuji Yakuhin Co.Ltd)
Article History
Received: 1 February 2023
Accepted: 15 April 2023
First Online: 26 April 2023
Declarations
:
: Masaki Ohya has received lecture fees from Kyowa Kirin Co, Ltd., Sanwa Kagaku Kenkyusho Co. Ltd. and Ono Pharmaceutical Co. Ltd. Takashi Shigematsu has received funding for the present study from Fuji Yakuhin Co. Ltd., and lecture fees from Kyowa Kirin Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd. and Ono Pharmaceutical Co. Ltd. Shin-ichi Araki has received lecture fees from Kyowa Kirin Co. Ltd., AstraZeneca Co. Ltd. and Mitsubishi Tanabe Pharma Corporation: research grants from Kyowa Kirin Co. Ltd. and Torii Pharmaceutical Co. Ltd. Other authors state that they have no conflicts of interest.